Glaucoma as a neurodegenerative disease
Glaucoma as a neurodegenerative disease is a valid working hypothesis to understand
neural injury in the visual system. This paradigm may stimulate the discovery of innovative …
neural injury in the visual system. This paradigm may stimulate the discovery of innovative …
What changes can we expect in the brain of glaucoma patients?
Elevated intraocular pressure in glaucoma can injure retinal ganglion cells and trigger the
spread of disease to connected target vision structures of the brain. Glaucomatous …
spread of disease to connected target vision structures of the brain. Glaucomatous …
A review of potential novel glaucoma therapeutic options independent of intraocular pressure
WS Shalaby, OM Ahmed, M Waisbourd, LJ Katz - Survey of Ophthalmology, 2022 - Elsevier
Glaucoma, a progressive optic neuropathy characterized by retinal ganglion cell
degeneration and visual field loss, is the leading cause of irreversible blindness worldwide …
degeneration and visual field loss, is the leading cause of irreversible blindness worldwide …
New paradigms in the mechanisms and management of glaucoma
HA Quigley - Eye, 2005 - nature.com
During the last 30 years, the definition of glaucoma as been revised to eliminate the
inclusion of intraocular pressure. Open angle glaucoma is the second leading cause of …
inclusion of intraocular pressure. Open angle glaucoma is the second leading cause of …
Links among glaucoma, neurodegenerative, and vascular diseases of the central nervous system
C Nucci, A Martucci, M Cesareo, F Garaci… - Progress in brain …, 2015 - Elsevier
Glaucoma is the leading cause of irreversible blindness worldwide. Although the intraocular
pressure (IOP) has been considered for long time the key point and the only treatable risk …
pressure (IOP) has been considered for long time the key point and the only treatable risk …
Is neuroprotection a viable therapy for glaucoma?
RN Weinreb, LA Levin - Archives of ophthalmology, 1999 - jamanetwork.com
Treatment of glaucoma continues to be directed at lowering intraocular pressure to decrease
the likelihood of disease progression. In the future intraocular pressure reduction might be …
the likelihood of disease progression. In the future intraocular pressure reduction might be …
[HTML][HTML] Neuroprotection in glaucoma: mechanisms beyond intraocular pressure lowering
Glaucoma is a common, complex, multifactorial neurodegenerative disease characterized
by progressive dysfunction and then loss of retinal ganglion cells, the output neurons of the …
by progressive dysfunction and then loss of retinal ganglion cells, the output neurons of the …
Neuroprotection in glaucoma
SK Vasudevan, V Gupta… - Indian journal of …, 2011 - journals.lww.com
Glaucoma is a neurodegenerative disease characterized by loss of retinal ganglion cells
and their axons. Recent evidence suggests that intraocular pressure (IOP) is only one of the …
and their axons. Recent evidence suggests that intraocular pressure (IOP) is only one of the …
[HTML][HTML] What is glaucoma?
D Križaj - Webvision: The Organization of the Retina and Visual …, 2019 - ncbi.nlm.nih.gov
Glaucoma, a leading cause of blindness in the world, can be challenging to diagnose
because symptoms often appear at late stage of the disease, and challenging to treat …
because symptoms often appear at late stage of the disease, and challenging to treat …
[HTML][HTML] Focus: the aging brain: neurodegeneration and neuroprotection in glaucoma
AC Gauthier, J Liu - The Yale journal of biology and medicine, 2016 - ncbi.nlm.nih.gov
Glaucoma is the principal cause of irreversible blindness in the world. The disease leads to
progressive optic nerve degeneration with a gradual loss of retinal ganglion cells …
progressive optic nerve degeneration with a gradual loss of retinal ganglion cells …